CClinicalTrials.gg
RecruitingNCT05790486TABRUpdated Feb 11, 2026

Take A Break - Rural

An interventional study of Take a Break plus Nicotine replacement therapy (NRT) Sampling and The Comparison in Smoking, Smoking Behaviors and Smoking Cessation, sponsored by Wake Forest University Health Sciences. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-11.

Sponsored by Wake Forest University Health Sciences · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Jul 2023; still recruiting 3 years 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
800
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The study team proposes a multi-level trial to test 1) novel implementation programs in rural counties designed to increase access to 2) recent advances in tobacco control services for people who are not-yet-ready-to-quit smoking. In this field, most trials have focused only on those already ready-to-quit. Thus, the proposed trial addresses an important knowledge gap critical to advance tobacco control in rural areas.

Read the detailed description

The study team will conduct a multi-level "hybrid type 2" study (i.e.: implementation and effectiveness outcomes) to test

1) a novel implementation program in rural counties and 2) a mHealth (mobile health)-assisted brief abstinence experience (Take a Break, TAB) for rural adults who smoke and are not-yet-ready to quit. In the network of rural counties, the implementation trial will use a novel, multi-strategy implementation program centered on county employees engaged in 'community paramedicine.' Emergency Medical Services personnel (EMS) are evolving into this more expansive role (e.g.: non-emergent healthcare delivery, monitoring of chronic disease, and preventive medicine). To test the implementation, the study team will randomize rural counties with EMS serving geographically complex and ethnically varied areas (the mountainous region of Appalachia and plains of eastern North Carolina). These counties have some of the highest smoking rates in the U.S. The team will compare a well tested (standard) implementation program versus a novel enhanced program. The standard program uses evidence-based external facilitation - providing training and technical support to EMS services to support the integration of enhanced tobacco control practices (including recommending and referring people who smoke and not-yet-ready-to-quit to the mHealth-assisted population health intervention. The novel enhanced implementation program will include the standard program an EMS Champion program. EMS who currently smoke will be offered participation in TAB themselves. Those who participate, Champions, will then use their TAB experience to support implementation as internal facilitators. They will encourage other EMS to experience TAB, longitudinally encourage use of the tobacco control practices in routine workflow for all EMS, and will be able to use their personal experience with TAB to engage in a richer dialog with patients who smoke. Using these strategies, the team seeks to engage individuals living in harder-to-reach rural areas with less access to clinical services.

Engaging these individuals is possible with brief, low intensity, palatable interventions that target self-efficacy and facilitate skills building to support future abstinence. The TAB intervention addresses the challenge of engaging lower motivated individuals using a novel format, a brief abstinence game, supported using mHealth and building upon 10 years of research. The team recently published the first TAB effectiveness trial in Journal of American Medical Association Internal Medicine. This preliminary data supports the current application and does not include a large number of individuals living in rural areas. In this project, the team will randomize to TAB versus an active comparison designed to isolate the effect of TAB and balance the participant contact across the two groups. In addition to evaluating implementation success and effectiveness outcomes, the team will study pathways to cessation. To inform sustainment and dissemination, the team will collect data on implementation fidelity, county-level adaptations, variations in referrals, and patient-level engagement across the counties, and at the EMS and patient-level. To evaluate budget impact, the team will track the cost of the implementation strategies and the intervention

02

Conditions studied

  • Smoking
  • Smoking Behaviors
  • Smoking Cessation

Keywords

  • smoking rates
  • public health tobacco control services
  • smoking cessation service
  • Rural Health
  • Implementation Science
  • Community Paramedicine
03

In context

Smoking

268 studies on the registry are indexed under Smoking; 136 are open to participants now.

This study's planned enrollment of 800 is above the median of 120 across 211 interventional studies indexed under Smoking.

Browse Smoking studies →

Lead sponsor

Wake Forest University Health Sciences is the lead sponsor of 1,320 studies on the registry; 199 are open to participants now.

Of its 323 completed or terminated interventional studies of FDA-regulated products, 243 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Current Smoker
  • at least 18 years old
  • speaks English
  • Able to receive texts and read text (literate)
  • Have a text-enabled phone or receive one from the study team
  • Not yet ready to quit smoking

Exclusion criteria

Exclusion Criteria:

  • actively quitting smoking
  • preparing to quit smoking within 30 days
  • prisoners
  • FDA- defined NRT contraindications
  • unable or unwilling to provide informed consent
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
800 participants (estimated)

Study arms

  • Experimental
    The Intervention: Take a Break plus Nicotine replacement therapy (NRT) Sampling

    Motivational text messages, challenge quizzes, goal-setting, coping mini-games, and recognition \& rewards. Nicotine lozenges will be given to all participants in both randomized groups.

    Behavioral: Take a Break plus Nicotine replacement therapy (NRT) Sampling

  • Active comparator
    The Comparison: Nicotine replacement therapy (NRT) Sampling without Take a Break

    Nicotine lozenges will be given to all participants in both randomized groups. The goal of the comparison group is to isolate the effect of the Take a Break experience.

    Behavioral: The Comparison

  • Experimental
    The Enhanced Program: Community Paramedicine Standard Plus Enhanced Implementation Program

    The Enhanced Program will include strategies described in the Standard Program plus training of local champions.

    Other: Community Paramedicine Standard Plus Enhanced Implementation Program

  • Active comparator
    The Standard Program: Community Paramedicine Standard Implementation Program

    The standard program will include training, resources, and access to the e-refer tool.

    Other: Community Paramedicine Standard Implementation Program

Interventions

  • BehavioralTake a Break plus Nicotine replacement therapy (NRT) Sampling

    Take a Break is an intervention in which smokers are encouraged to engage in smoking abstinence. The main element, the "Break," is a two-week challenge where smokers report days they are smoke-free. The Break is preceded by a 1-week training challenge where Challenge Quizzes (ecological momentary assessments) collect information to guide the smokers during the Break. At baseline, all smokers will be provided NRT lozenges for sampling. At week 1 of the "Marathon", our Tobacco Treatment Specialist will call all smokers, assess their experiences and facilitate an abstinence goal.

  • BehavioralThe Comparison

    The comparison group will receive Nicotine Replacement Therapy sampling and will be balanced in all variables except the Take a Break Intervention.

  • OtherCommunity Paramedicine Standard Plus Enhanced Implementation Program

    Counties randomized to the enhanced program will receive the standard implementation program plus the following enhancements. We will engage and train local implementation champions. The EMS Implementation Champion will go through the Take a Break Intervention but will not receive NRT sampling. The local implementation champions are internal facilitators with additional knowledge and experience related to the electronic referral process. The champions will also be leaders in their county by trying to improve referrals, remind EMS personnel, and distribute feedback on the performance of the county.

  • OtherCommunity Paramedicine Standard Implementation Program

    In counties randomized to the standard program, we will engage EMS leaders and train local personnel. The training will be applying the Ask-Advise-Refer model and the use of an eRefer tool in EMS situations and conditions. The EMS will then engage smokers in the field or community to use the Ask-Advise-Refer training to submit electronic referrals with the eRefer tool.

06

What researchers measure

Primary outcomes

  1. Number of participants engaged

    Referral rate of participants by EMS personnel

    Time frame: Monthly from initial training to end of referral period year 1 to year 4 longitudinally

  2. Follow-up smoking cessation

    Point prevalent cessation is measured by the number of participants with a decreased carbon monoxide level as verified by carbon monoxide levels in blood.

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • Wake Forest University Health Sciences
    Winston-Salem, North Carolina 27157, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05790486
Lead sponsor
Wake Forest University Health Sciences
Collaborators
National Cancer Institute (NCI), University of Massachusetts, Worcester
Responsible party
Sponsor
First posted
Mar 30, 2023
Start date
Jul 11, 2023
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Feb 11, 2026

Study contacts

Anna M Thorpe
Contact
Anna.Thorpe@advocatehealth.org
336-716-3028
Erica Hale, MS
Contact
Erica.Hale@Advocatehealth.org
336-716-2236
Thomas K Houston, MD, MPH
principal investigator · Wake Forest University Health Sciences
Rajani Sadasivam, PhD
principal investigator · UMass Chan Medical School

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion